The trials primary result was a 20% reduction in 3-point MACE over a mean follow-up of 39.8 months (HR 0.80, 95% CI 0.720.90) [3]
Also, the IPO was fully an Offer for Sale (OFS) , meaning the existing owners were cashing out rather than raising new money for growth , and the stock is priced at a steep 70x earnings , which feels expensive compared to some peers
Epilepsy isnt listed as a contraindication for Wegovy in the prescribing information
Why is 2.5mg the starting dose of Mounjaro
So if you get the cookie flavor, there is gonna be bits of cookie in there
Little SA, Speight J, Leelarathna L et al (2018) Sustained reduction in severe hypoglycemia in adults with type 1 diabetes complicated by impaired awareness of hypoglycemia: two-year follow-up in the HypoCOMPaSS randomized clinical trial